Skip to content

Determination of Longus Colli Muscle Thickness by Ultrasonography

How Far Should The Needle Be Withdrawn for Stellate Ganglion Block: Determination of Longus Colli Muscle Thickness by Ultrasonography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05108103
Enrollment
200
Registered
2021-11-04
Start date
2021-03-01
Completion date
2022-06-01
Last updated
2022-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndromes, Hyperhidrosis, Pain, Intractable, Pain Syndrome

Keywords

Stellate Ganglion, Longus Colli Muscle, Ultrasound

Brief summary

This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks

Detailed description

Stellate ganglion block is an interventional pain management procedure that is often performed for diagnostic and therapeutic purposes. It has long been performed with the guidance of fluoroscopy, and despite the increasing use of ultrasonography in recent years, fluoroscopy is still the gold standard method. In traditional fluoroscopic method, the needle is directed to the transverse process of the C6 vertebra, after touching the anterior tubercle (Chassaignac's tubercule) the needle is slightly withdrawn and following a negative aspiration, injection is performed. The ideal placement of the needle should be anterolateral to the longus colli muscle and deep to the prevertebral fascia. Further placement may cause intramuscular spread and superficial placement may cause injection in the carotid sheath or vascular structures. These are the most important reasons for clinical ineffectiveness. How far should the needle be withdrawn? Data is inconsistent in the literature. The primary aim of this study is to determine the distance from transverse process to longus colli muscles anterior border and from transverse process to carotid sheath's posterior border. Secondary aim is to investigate the relationship between longus colli muscle thickness and age, gender, height, weight, BMI and neck circumference.

Interventions

None listed

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 - 65 years, * Giving informed consent for examination, ultrasonographic evaluation and study participation

Exclusion criteria

* Having a chronic neck pain for more than 6 months, * Having any neurological or musculoskeletal conditions that may affect the anatomy of cervical region (cervical disc herniation, torticollis, severe scoliosis, vertebral malformation, spinal stenosis, myopathies, etc.) * Having a history of surgery or radiation therapy in the cervical region

Design outcomes

Primary

MeasureTime frameDescription
Distance between corpus and longus colli muscle's anterior border on C6 level (millimeters)0 minutesDistance between corpus and longus colli muscle's anterior border on C6 level will be evaluated with ultrasonography.

Secondary

MeasureTime frameDescription
Distance between corpus and longus colli muscle's anterior border on C7 level (millimeters)0 minutesDistance between corpus and longus colli muscle's anterior border on C7 level will be evaluated with ultrasonography.
Maximum anteroposterior width of longus colli muscle on C6 level (millimeters)0 minutesMaximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.
Maximum anteroposterior width of longus colli muscle on C7 level (millimeters)0 minutesMaximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.
Distance between esophagus and estimated needle plane (millimeters)0 minutesDistance between esophagus and estimated needle plane will be evaluated with ultrasonography.
Neck circumference (centimeters)0 minutesNeck circumference

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026